Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.
about
Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.Donor-Specific Antibodies in Kidney Transplant Recipients.SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production.
P2860
Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Bortezomib in the treatment of ...... c Nephrology Consortium study.
@en
Bortezomib in the treatment of ...... c Nephrology Consortium study.
@nl
type
label
Bortezomib in the treatment of ...... c Nephrology Consortium study.
@en
Bortezomib in the treatment of ...... c Nephrology Consortium study.
@nl
prefLabel
Bortezomib in the treatment of ...... c Nephrology Consortium study.
@en
Bortezomib in the treatment of ...... c Nephrology Consortium study.
@nl
P2093
P2860
P356
P1476
Bortezomib in the treatment of ...... c Nephrology Consortium study.
@en
P2093
Ashton Chen
Donna Claes
Isa Ashoor
Joseph Sherbotie
Priya Verghese
Raed Bou Matar
Sara Jandeska
Sarah Kizilbash
P2860
P356
10.1111/PETR.12873
P577
2017-01-16T00:00:00Z